Status
Conditions
Treatments
About
The goal of this clinical study was to learn whether a skincare regimen personalized by an artificial intelligence (AI) skin-analysis tool improves signs of facial skin aging in women aged 35 to 65 with mild-to-moderate facial photoaging. The main questions it aimed to answer were: Does the personalized regimen improve fine lines, wrinkles, firmness, smoothness, tone and other signs of skin aging after 4 and 12 weeks of use? Is the regimen well tolerated? Participants completed an online skin questionnaire and uploaded a facial selfie, and the AI tool assigned one of three night creams. Each participant then used a personalized kit at home for 12 weeks: a vitamin C serum and SPF 30 sunscreen in the morning; the assigned night cream (0.3% retinol, 0.6% retinol, or bakuchiol, each with a triple-peptide complex), an eye cream, and a dark spot remover in the evening; and a daily oral marine collagen supplement. Participants visited the clinic at baseline, week 4 and week 12 for expert skin grading, skin measurements, photographs and questionnaires.
Full description
This was a 12-week, single-center, single-arm, subject-blinded study (Protocol C25-D123, version 1.0) conducted at SGS North America Inc. (Richardson, TX, USA) and approved by Sterling Institutional Review Board (IRB ID 14718) on September 26, 2025. Product labels were covered with opaque tape so participants were blinded to the ingredients and formulation assigned.
Personalization: Each participant completed an online questionnaire (skin concerns, sensitivities, environmental exposures and lifestyle) and uploaded a facial selfie that was analyzed by a proprietary AI system for wrinkle severity, pigmentation and texture. Based on this analysis, each participant was assigned one of three night creams: Cream A (0.3% retinol with the SenoP3 triple-peptide complex) for sensitive skin or early aging, Cream B (0.6% retinol with SenoP3) for moderate photoaging with established retinoid tolerance, or Cream C (bakuchiol with SenoP3) for retinoid-sensitive skin.
Regimen: Morning - 10% tetrahexyldecyl ascorbate vitamin C serum and SPF 30 sunscreen. Evening - assigned night cream, eye cream with SenoP3, and dark spot remover as needed. Daily - oral wild-caught marine collagen supplement (type I collagen peptides).
Assessments at baseline, week 4 and week 12: expert clinical grading on a modified Griffiths 10-point scale; standardized VISIA photography; PRIMOS 3D profilometry (roughness, wrinkle depth and volume at crow's feet, forehead and perioral areas); Corneometer (hydration), Tewameter (transepidermal water loss) and Indentometer (firmness) under controlled conditions; subject self-assessment questionnaires; and adverse event monitoring. Comparisons between night-cream subgroups were exploratory.
This study is being registered retrospectively after completion.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
-
Inclusion Criteria:
Exclusion criteria
Exclusion Criteria:
-
Primary purpose
Allocation
Interventional model
Masking
43 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal